Oncology Nursing Update: Newly Diagnosed Multiple Myeloma — An Interview with Ms Charise Gleason on Optimizing Patient Care
Update: 2025-09-06
Description
Featuring an interview with Ms Charise Gleason, including the following topics:
- Progress and change in the management of multiple myeloma (MM) (0:00 )
- Patient- and disease-specific factors guiding therapeutic decision-making for newly diagnosed MM (5:11 )
- Role of anti-CD38 antibodies in the management of MM (12:14 )
- Emerging treatment options for smoldering myeloma (23:08 )
- Optimizing long-term outcomes for patients with MM (25:38 )
- Tailoring therapy for older adults and patients with preexisting comorbidities (29:59 )
- Case: A woman in her early 80s with newly diagnosed transplant-ineligible MM who experienced a complete response with first-line daratumumab/lenalidomide and low-dose dexamethasone (34:34 )
- Case: A man in his early 60s with progressive back pain from standard-risk MM who experienced a complete response with daratumumab with lenalidomide/bortezomib/dexamethasone (42:05 )
- Building therapeutic relationships and integrating holistic care in oncology practice (47:13 )
Comments
In Channel